(Press-News.org) A newly developed compound is showing promise in animal studies as a more effective treatment for human schistosomiasis, an understudied tropical disease caused by parasitic worms. The spread of schistosomiasis, a disease responsible for nearly 12,000 deaths globally each year, has been documented in 78 nations.
Although schistosomiasis transmission tends to occur in tropical and subtropical areas, climate change could shift it into new areas such as southern Europe. There is currently no vaccine available for the disease, which comes with severe clinical symptoms. The drug praziquantel is used for treatment. However, resistant mutations are reducing praziquantel’s efficacy, and the drug doesn’t kill the larval-stage parasites.
Sevan N. Alwan, an assistant professor at The University of Texas Health Science Center at San Antonio, led the research team.
“The infection can become reactivated when the larva develop into adult parasites, which comes with more severe symptoms and higher transmission rates,” said Alwan, an assistant professor at The University of Texas Health Science Center at San Antonio. “The compound we developed overcomes the limitations of praziquantel by being effective against the larval stage and resistant strains.”
Alwan will present the research at Discover BMB, the annual meeting of the American Society for Biochemistry and Molecular Biology, which will be held March 23–26 in San Antonio.
“In recent reports, the cure rates for praziquantel were 60% in Sub-Saharan Africa, where the disease is highly endemic,” said Alwan. “The drug limitations strongly warrant the need for new therapeutics with a distinctly different mechanism of action to reach a better cure rate.”
The new compound was developed as part of the research team’s effort to design, synthesize and test reengineered derivatives of oxamniquine, which was previously used to treat patients with parasite but is no longer used due to drug resistance and limited effectiveness.
The researchers developed and tested 350 compounds. Five of these killed human Schistosoma species as well as a praziquantel-resistant strain in animal models.
One of these compounds, called CIDD-0149830, also killed larval parasites in experiments with cultured cells and a mouse model of the disease. In experimental groups of five female mice each, the number of larval worms was reduced by 71.7% with CIDD-0149830, while praziquantel reduced them by only 21.1%. The study also showed that CIDD-0149830 reduced the number of eggs more effectively.
“In addition to being effective against the larval stage and resistant strains, CIDD-0149830 also overcomes the limitation of oxamniquine by being effective against two major species of the parasite in animal models and can effectively treat mixed infection by these two species,” Alwan said.
Although the new results are promising, the researchers caution that they must still determine dosing for humans and perform safety and toxicity studies to make sure the treatment is safe for human use. They also plan to conduct experiments with male and female mice to assess whether sex influences the outcome of worm burden and morbidity.
Sevan N. Alwan will present this research during a poster session from 4:30 to 6:30 p.m. CDT on Sunday, March 24, in the exhibit hall of the Henry B. González Convention Center (Poster Board No. 56) (abstract). Contact the media team for more information or to obtain a free press pass to attend the meeting.
Image available.
About the American Society for Biochemistry and Molecular Biology (ASBMB)
The ASBMB is a nonprofit scientific and educational organization with more than 12,000 members worldwide. Founded in 1906 to advance the science of biochemistry and molecular biology, the society publishes three peer-reviewed journals, advocates for funding of basic research and education, supports science education at all levels, and promotes the diversity of individuals entering the scientific workforce. www.asbmb.org
Find more news briefs and tipsheets at: https://discoverbmb.asbmb.org/newsroom.
###
END
New research conducted in mice offers insights into what’s going on at the molecular level that could cause people with diabetes to develop Alzheimer’s disease.
The study adds to a growing body of research on the links between Type 2 diabetes and Alzheimer’s disease, which some scientists have called “Type 3 diabetes.” The findings suggest that it should be possible to reduce the risk of Alzheimer’s by keeping diabetes well controlled or avoiding it in the first place, according to researchers.
Narendra Kumar, an associate professor at Texas A&M University in College ...
A new way to classify tuberculosis (TB) that aims to improve focus on the early stages of the disease has been presented by an international team involving researchers at UCL.
The new framework, published in The Lancet Respiratory Medicine, seeks to replace the approach of the last half century of defining TB as either active (i.e., causing illness and potentially infectious to others) or latent (being infected with the bacterium that causes TB [M tuberculosis] but feeling well and not infectious to others) – an approach researchers say is limiting progress in eradicating the disease.
Of ...
**Note: the release below is a special early release from the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024, Barcelona, Spain, 27-30 April). Please credit the congress if you use this story**
A study of two large European patient cohorts has found that for every 10% increase in butyrate-producing bacteria in a patient’s gut, the risk of hospitalisation for any infection falls by between 14 and 25% across two large national cohorts. The study will be presented at this year’s European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024) in Barcelona, Spain (27-30 April) and is by ...
Research led by Macquarie University sheds new light on how concentrations of metals used in renewable energy technologies can be transported from deep within the Earth's interior mantle by low temperature, carbon-rich melts.
The findings published this week in the journal Science Advances may assist global efforts to find these valuable raw materials.
An international team led by Dr Isra Ezad, a postdoctoral research fellow from Macquarie University’s School of Natural Sciences, carried out high pressure ...
A new study in the peer-reviewed journal Diabetes Technology & Therapeutics (DTT) evaluated the use of tirzepatide in overweight/obese adults with type 1 diabetes. Click here to read the article now.
Tirzepatide is approved for managing type 2 diabetes. It improves glucose control, facilitates weight loss, and improves cardiovascular disease outcomes.
Satish Garg, MD, from the University of Colorado Denver, and coauthors, compared a group of adults with type 1 diabetes who were prescribed tirzepatide (off-label) to a control group of adults with ...
It’s one of life’s most defining moments—that crucial step in embryonic development, when an indistinct ball of cells rearranges itself into the orderly three-layered structure that sets the stage for all to come. Known as gastrulation, this crucial process unfolds in the third week of human development. “Gastrulation is the origin of our own individualization, the emergence of our axis,” says Rockefeller’s Ali Brivanlou. “It is the first moment that separates our heads from our behinds.”
Observing the molecular underpinnings of this pivotal event would go a long way toward helping scientists prevent miscarriages and developmental ...
CORVALLIS, Ore. – Arachnophobia can make humans flee at the sight of a brown recluse, black widow or even a daddy long legs, but animal predators of spiders know no such fear.
That’s why, paleobiologist George Poinar Jr. explains, some spider species have developed the defense of deception. They masquerade as a much less desirable prey – ants – and Poinar’s recent paper in Historical Biology presents an early record of an ant-mimicking spider in fossilized resin.
“Ants are particularly good creatures for spiders to pretend to be – many animals ...
In cases of Alzheimer’s disease, it’s common for a spouse to take on the role of caregiver. Research led by the University of California, Davis, suggests that patients can also support their caretakers, and that reciprocated care has mutual benefits.
A new paper published in the journal Aging and Mental Health highlights that couples coping with dementia can navigate the challenges with greater resilience and well-being by working together and supporting each other.
“We know that dementia is degenerative, there’s no way back, and spousal caregivers typically ...
RIVERSIDE, Calif. -- Physicist Nathaniel Gabor at the University of California, Riverside, has been awarded a $7.5M grant from the Department of Defense, or DoD, to develop a Multidisciplinary University Research Initiatives, or MURI, center on campus. Called QuVET for the Center for Quantum Vibronics in Energy and Time, the center’s co-principal investigators are leading scientists at UCR, Caltech, MIT, and Columbia University.
“Vibronic,” a portmanteau of vibrational and electronic, refers to transitions between molecular energy states. ...
MSU has a satellite uplink/LTN TV studio and Comrex line for radio interviews upon request.
EAST LANSING, Mich. – Research has often focused on how teachers and educators can best instruct and accommodate students with disabilities. However, are the methods used to teach students with disabilities effective and inclusive for all students? Michigan State University researchers are some of the first to answer that question.
Faculty and doctoral students from across MSU, including from the College of Social Science and the College of ...
